Skip to content

Comparison of quality of life and cost effectiveness in Entropion patient with Meibomian gland dysfunction treatment between Quickert suture and medical treatment

Comparison of quality of life and cost effectiveness in Entropion patient with Meibomian gland dysfunction treatment between Quickert suture and medical treatment

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240504004
Enrollment
50
Registered
2024-05-04
Start date
2024-10-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The quality of life and cost effectiveness of patients with entropion and meibomian gland dysfunction who receive quickert suture, in comparison to those who are only treated with medications. Entropion, Meibomian gland dysfunction, Quality of life, Quickert suture, lipid layer thickness

Interventions

Sponsors

Mettapracharak Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Thai citizens who are 18 years of age and above 2. Spastic or involutional entropion with meibomian gland dysfuction 3. Require entropion eyelid surgical repair

Exclusion criteria

Exclusion criteria: 1. History of eyelid surgery 2. Appointment of eyelid surgery is within the next 6 months 3. Chronic inflammatory eye diseases that are poor controlled, such as Thyroid eye disease or Steven Johnson syndrome 4. Allergic to fluorescein 5. The patient is unable to follow up as per protocol 6. The patient is unable to communicate the ocular symptoms 7. The patient denys further treatment

Design outcomes

Primary

MeasureTime frame
Ocular surface disease index score Baseline, 1 week, 1 month, 3 months, 6 months score

Secondary

MeasureTime frame
Health care costs Baseline, 1 week, 1 month, 3 months, 6 months Baht

Countries

Thailand

Contacts

Public ContactFahsiri Tavonvunchai

Mettapracharak Hospital

fahsiri.t@gmail.com0830024928

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026